Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 176

Sort by

Sort Order Select

Journal Articles

Treatment and Outcomes in Heparin-Induced Thrombocytopenia (HIT) in Patients with Neoplasm: A Single Centre Experience

Chieh Min Lai, MD PhD, Tyler Smith, MD, Agnes Yuet Ying Lee, MD MSc, FRCPC

Blood (2019) 134 (Supplement_1): 4951.

https://doi.org/10.1182/blood-2019-122389

Published: 2019

Journal Articles

Anticoagulation Increases Bleeding Rates in Portal Vein Thrombosis: A National Database Study

Omar Ali Alaber, MD, Apoorva Krishna Chandar, MDMPH, Basma Ali Dahash, MD, Sohi N Mistry, BS, Stanley Martin Cohen, MD, Amitabh Chak, MD, Ankit Mangla, MBBS, MD

Blood (2019) 134 (Supplement_1): 5860.

https://doi.org/10.1182/blood-2019-131226

Published: 2019

Journal Articles

The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease

Vishal K Gupta, MD, Romy Carmen Lawrence, MD BS, Sarah L. Khan, Rachel Strykowski, MD, Brittany Scarpato, MD, Robyn T. Cohen, MD MPH, John Mark Sloan, MD, Elizabeth S Klings, MD

Blood (2019) 134 (Supplement_1): 2272.

https://doi.org/10.1182/blood-2019-122113

Published: 2019

Journal Articles

Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass

Nabil K. Thalji, MD PhD, Prakash A Patel, MD, Rodney M. Camire, PhD

Blood (2019) 134 (Supplement_1): 3640.

https://doi.org/10.1182/blood-2019-125955

Published: 2019

Journal Articles

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Tariq Zuheir Kewan, MD, Shafia Rahman, MBBS, Fahrettin Covut, MD, Ramsha Ahmed, MD, Seba Hasan, Yihong Zhou, MD, Alok A Khorana, MD

Blood (2019) 134 (Supplement_1): 3683.

https://doi.org/10.1182/blood-2019-131758

Published: 2019

Journal Articles

Andexanet Alpha Differentially Neutralizes the Anticoagulant, Antiprotease and Thrombin Generation Inhibitory Effects of Unfractionated Heparin, Enoxaparin and Fondaparinux

Fakiha Siddiqui, Alfonso J Tafur, MD MS, Debra Hoppensteadt, PhD, Jeanine Walenga, PhD, Walter Jeske, PhD, Emily Bontekoe, Ahmed Kouta, Jawed Fareed, PhD

Blood (2019) 134 (Supplement_1): 1158.

https://doi.org/10.1182/blood-2019-127072

Published: 2019

Journal Articles

Indications, Efficacy and Complications of Kcentra Use in Reversing Coagulopathy

Nithya Sritharan, MD, Darrell Triulzi, MD

Blood (2018) 132 (Supplement 1): 3820.

https://doi.org/10.1182/blood-2018-99-119988

Published: 2018

Journal Articles

A Restructured Approach to Diagnosis of Heparin Induced Thrombocytopenia in a Large Tertiary Hospital

Sriman Swarup, MD MBBS, Somedeb Ball, MD, Nimesh Adhikari, MD, Courtney Alice Welch, Jaden Fackrell, MS, Kyaw Zin Thein, MD MBBS, Anita Sultan, MD, Khatrina Swarup, RN, Sanjay Awasthi, MD, Lukman Tijani, MD

Blood (2018) 132 (Supplement 1): 3525.

https://doi.org/10.1182/blood-2018-99-114265

Published: 2018

Journal Articles

Confirmation of the Utility of the 4T Scoring System for HIT

Zachary Trisel, MD, Mark Maddox, DO, Ahmed Safa, MD, Thomas Bemis, MD, Kristine Ward, MD, Michael Styler, MD

Blood (2018) 132 (Supplement 1): 5816.

https://doi.org/10.1182/blood-2018-99-119573

Published: 2018

Journal Articles

Appropriateness of Heparin-Induced Thrombocytopenia (HIT) Testing and the Reliability of 4-Ts Scoring in Critically Ill Patients

Phyo Thazin Myint, MDMSc, Amani Erra, MD, Taha Alrifai, MD, Salman Syed, MD, Bibek Singh Pannu, MD, Shyam Chalise, MD, Kelley E. Kozma, DO

Blood (2018) 132 (Supplement 1): 4988.

https://doi.org/10.1182/blood-2018-99-114788

Published: 2018

Journal Articles

Incidence, Clinical Profile and Outcome of Patients with Deep Vein Thrombosis and Pulmonary Embolism at a Community Hospital

Pragathi Balakrishna, MD, Mehdi M. Moezi, MD, Furquan Pathan, MD

Blood (2017) 130 (Supplement 1): 5585.

https://doi.org/10.1182/blood.V130.Suppl_1.5585.5585

Published: 2017

Journal Articles

Heparin-Induced Thrombocytopenia with Very High Antibody Titer Is Associated with Slower Platelet Recovery

Akash Mukherjee, MD, Asmita Patel, Joe Ensor, PhD, Ibrahim F. Ibrahim, MD, Kelty R. Baker, MD, Lawrence Rice, MDBA

Blood (2017) 130 (Supplement 1): 3623.

https://doi.org/10.1182/blood.V130.Suppl_1.3623.3623

Published: 2017

Journal Articles

Recognizing the Existence of Heparin Induced Thrombocytopenia and Thrombosis in the Setting of High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Case Series

Shayna Sarosiek, MD, Karen Quillen, MDMPH, John Mark Sloan, MD, Dina Brauneis, NP, Vaishali Sanchorawala, MD

Blood (2017) 130 (Supplement 1): 3643.

https://doi.org/10.1182/blood.V130.Suppl_1.3643.3643

Published: 2017

Journal Articles

Anticoagulant Prescription Patterns for Cancer Associated Thrombosis: New Insights into the Use of Direct Oral Anticoagulants

Dana E. Angelini, MD, Paul Elson, PhD, Keith McCrae, MD, Alok A. Khorana, MD

Blood (2017) 130 (Supplement 1): 4725.

https://doi.org/10.1182/blood.V130.Suppl_1.4725.4725

Published: 2017

Journal Articles

Diagnosis and Management of Paget-Schroetter Syndrome in Children: An Institutional Experience

Katherine L Harsh, BS, Surbhi Saini, MD, Joseph R Stanek, MS, Sarah O'Brien, MD MSc, Patrick Warren, MD, Riten Kumar, MDMSc

Blood (2017) 130 (Supplement 1): 699.

https://doi.org/10.1182/blood.V130.Suppl_1.699.699

Published: 2017

Journal Articles

Unfractionated Heparin Use in Children: Clinical Outcomes in a Pediatric Cohort Managed Using an Anti-Factor Xa Based Nomogram

Surbhi Saini, MD, Katherine L Harsh, BS, Joseph R Stanek, MS, Sarah O'Brien, MD MSc, Amy L. Dunn, MD, Riten Kumar, MD MSc

Blood (2017) 130 (Supplement 1): 701.

https://doi.org/10.1182/blood.V130.Suppl_1.701.701

Published: 2017

Journal Articles

A 2 Year of Review of HIT Evaluations at an Urban Medical Center with an Aim Towards Quality Improvement and the Development of Practical Testing Strategies

Stephen Zachary Peeke, MD, Ilan Shapira, MD, Ismini Kourouni, MD

Blood (2017) 130 (Supplement 1): 2322.

https://doi.org/10.1182/blood.V130.Suppl_1.2322.2322

Published: 2017

Journal Articles

The Use of 4F-PCC to Correct Direct Oral Anticoagulant (DOAC)-Induced Coagulopathy: An Observational Analysis

Yan Zheng, MD PhD, Christopher Tormey, MD

Blood (2017) 130 (Supplement 1): 4912.

https://doi.org/10.1182/blood.V130.Suppl_1.4912.4912

Published: 2017

Journal Articles

A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism

Alexander G. G. Turpie, MD, Lorenzo G Mantovani, Sylvia Katharina Haas, MD PhD, Reinhold Kreutz, PhD, Danja Monje, Jonas Schneider, Martin van Eickels, Miriam Tamm, Martin Gebel, Walter Ageno

Blood (2017) 130 (Supplement 1): 2386.

https://doi.org/10.1182/blood.V130.Suppl_1.2386.2386

Published: 2017

Journal Articles

Synthetic Pentasaccharide Fondaparinux (Arixtra ® ) Reduces Sepsis Induced Coagulopathy and Promotes Survival in the Baboon Model of E. coli Sepsis

Ravi Shankar Keshari, PhD, Robert Silasi, PhD, Narcis Ioan Popescu, PhD, Cristina Lupu, PhD, Charles Esmon, PhD, Florea Lupu, PhD

Blood (2017) 130 (Supplement 1): 2375.

https://doi.org/10.1182/blood.V130.Suppl_1.2375.2375

Published: 2017

NARROW

Treatment and Outcomes in Heparin-Induced Thrombocytopenia (HIT) in Patients with Neoplasm: A Single Centre Experience

Anticoagulation Increases Bleeding Rates in Portal Vein Thrombosis: A National Database Study

The Effect of Anticoagulant Choice on Venous Thromboembolism Recurrence and Bleeding in Sickle Cell Disease

Administration of Andexanet Alfa for Direct Factor Xa Inhibitor Reversal Precludes Therapeutic Heparinization for Cardiopulmonary Bypass

Risk of Intracerebral Hemorrhage with and without Anticoagulation in Patients with Brain Metastasis: The Cleveland Clinic Experience

Andexanet Alpha Differentially Neutralizes the Anticoagulant, Antiprotease and Thrombin Generation Inhibitory Effects of Unfractionated Heparin, Enoxaparin and Fondaparinux

Indications, Efficacy and Complications of Kcentra Use in Reversing Coagulopathy

A Restructured Approach to Diagnosis of Heparin Induced Thrombocytopenia in a Large Tertiary Hospital

Confirmation of the Utility of the 4T Scoring System for HIT

Appropriateness of Heparin-Induced Thrombocytopenia (HIT) Testing and the Reliability of 4-Ts Scoring in Critically Ill Patients

Incidence, Clinical Profile and Outcome of Patients with Deep Vein Thrombosis and Pulmonary Embolism at a Community Hospital

Heparin-Induced Thrombocytopenia with Very High Antibody Titer Is Associated with Slower Platelet Recovery

Recognizing the Existence of Heparin Induced Thrombocytopenia and Thrombosis in the Setting of High-Dose Melphalan and Autologous Stem Cell Transplantation: A Single Institution Case Series

Anticoagulant Prescription Patterns for Cancer Associated Thrombosis: New Insights into the Use of Direct Oral Anticoagulants

Diagnosis and Management of Paget-Schroetter Syndrome in Children: An Institutional Experience

Unfractionated Heparin Use in Children: Clinical Outcomes in a Pediatric Cohort Managed Using an Anti-Factor Xa Based Nomogram

A 2 Year of Review of HIT Evaluations at an Urban Medical Center with an Aim Towards Quality Improvement and the Development of Practical Testing Strategies

The Use of 4F-PCC to Correct Direct Oral Anticoagulant (DOAC)-Induced Coagulopathy: An Observational Analysis

A Pooled Analysis of the Xalia and Xalia-Lea Non-Interventional Studies of Rivaroxaban Versus Standard Anticoagulation in Venous Thromboembolism

Synthetic Pentasaccharide Fondaparinux (Arixtra ® ) Reduces Sepsis Induced Coagulopathy and Promotes Survival in the Baboon Model of E. coli Sepsis

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only